RT Journal Article
SR Electronic
T1 Development of an electronic frailty index for hospitalized geriatric patients in Sweden
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.26.21266912
DO 10.1101/2021.11.26.21266912
A1 Mak, Jonathan K. L.
A1 Hägg, Sara
A1 Eriksdotter, Maria
A1 Annetorp, Martin
A1 Kuja-Halkola, Ralf
A1 Kananen, Laura
A1 Boström, Anne-Marie
A1 Kivipelto, Miia
A1 Metzner, Carina
A1 Jerlardtz, Viktoria Bäck
A1 Engström, Malin
A1 Johnson, Peter
A1 Lundberg, Lars Göran
A1 Åkesson, Elisabet
A1 Öberg, Carina Sühl
A1 Olsson, Maria
A1 Cederholm, Tommy
A1 Jylhävä, Juulia
A1 Religa, Dorota
YR 2021
UL http://medrxiv.org/content/early/2021/11/28/2021.11.26.21266912.abstract
AB Background Frailty assessment in the Swedish health system relies on the Clinical Frailty Scale (CFS), but it requires training, in-person evaluation, and is often missing in medical records. We aimed to develop an electronic frailty index (eFI) from routinely collected electronic health records (EHRs) and assess its predictive ability for adverse outcomes in geriatric patients.Methods EHRs were extracted for 18,225 geriatric patients with unplanned admissions between 1/3/2020 and 17/6/2021 from nine geriatric clinics in Stockholm, Sweden. A 48-item eFI was constructed using diagnostic codes, functioning and other health indicators, and laboratory data. The CFS, Hospital Frailty Risk Score, and Charlson Comorbidity Index were used for comparative assessment of the eFI. We modelled in-hospital mortality and 30-day readmission using logistic regression; 30-day and 6-month mortality using Cox regression; and length of stay using linear regression.Results 13,188 patients were included in analyses (mean age 83.1 years). A 10% increment in the eFI was associated with higher risks of in-hospital (odds ratio: 5.34; 95% confidence interval: 4.20-6.82), 30-day (hazard ratio [HR]: 3.28; 2.91-3.69), and 6-month mortality (HR: 2.70; 2.52-2.90) adjusted for age and sex. Of the frailty and comorbidity measures, the eFI had the best predictive accuracy for in-hospital mortality, yielding an area under receiver operating characteristic curve of 0.813. Higher eFI also predicted a longer length of stay, but had a rather poor discrimination for 30-day readmission.Conclusions An EHR-based eFI has good predictive accuracy for adverse outcomes, suggesting that it can be used in risk stratification in geriatric patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported financially by the Swedish Research Council grants (2018-02077, 2020-02014, 2020-06101), the regional agreement on medical training and clinical research between the Stockholm County Council and the Karolinska Institutet (ALF), the Strategic Research Area in Epidemiology and Biostatistics grant, the Academy of Finland through its funding to the Centre of Excellence in Research of Ageing and Care (CoEAgeCare, grant numbers 335870, 326567 and 336670), Lakarsallskapet and Gosta Miltons Donationsfond grant, and the Stockholm University - Region Stockholm grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Swedish Ethical Review Authority (Dnr 2020-02146, 2020-03345, 2021-00595, 2021-02096).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.